Michael Burry Questions AI Safety Talk as Cover for Slowing Growth

IndustryManagement
โดย GuruFocus·US·Read original
Summary · why it matters

Michael Burry is challenging the AI industry's biggest players, arguing that calls to slow frontier AI development may be less about safety and more about protecting incumbents as competition intensifies and growth becomes harder to sustain. Writing on X, Burry said it is self-serving for OpenAI, Anthropic and other executives of big hyperscalers to talk of slowing things down, and laid out four arguments, most strikingly that slowing development would benefit existing AI leaders just as challengers begin closing the gap. He questioned whether warnings about increasingly dangerous AI could help support lofty private-market valuations ahead of IPOs, calling that argument hype and puffery, and accused safety concerns of providing cover for real uncontrollable slowing growth as IPOs look to be pushed out. The timing is sensitive: OpenAI and Anthropic submitted initial IPO filings earlier this summer, but OpenAI CEO Sam Altman has said the company will not go public this year because it would come at an ill-advised moment, while Anthropic CEO Dario Amodei has argued AI capability progress should slow, a position Altman and Elon Musk both endorsed. For investors, the key issue is whether frontier-model development is being deliberately paced because risks are rising, or whether economics are becoming less attractive as models get more expensive to train and competition increases, with Microsoft and Alphabet investors watching AI revenue growth, cloud demand, capital spending and returns on infrastructure investment, and OpenAI and Anthropic IPO timing, revenue growth and funding requirements offering the clearest test of Burry's thesis.

Impact on stocks 2

Artificial Intelligence▲ · 2 stocks
Alphabet Inc Class C
GOOG
± Mixedrelevance

Mentioned as a hyperscaler whose AI revenue growth, cloud demand and capex investors are watching amid Burry's thesis; no company-specific development.

Microsoft Corporation
MSFT
± Mixedrelevance

Named as a hyperscaler whose AI revenue growth, cloud demand and infrastructure returns investors are watching; no company-specific development.

Theme Impact 2

Off-coverage companies 2

AnthropicPrivate± Mixed
relevance

Burry says Anthropic's calls to slow AI development may protect incumbents; its IPO timing and revenue growth are cited as a test of his thesis, with no new company-specific fact.

OpenAIPrivate± Mixed
relevance

Burry argues OpenAI's safety talk may mask slowing growth and delayed IPO; IPO timing and funding are the test of his thesis, but no concrete new development.

Related news

Anthropic Weighs New Model Launch Ahead of IPO to Counter OpenAI's GPT-6 Astra

Artificial intelligence developer Anthropic is considering launching a new model ahead of its initial public offering, according to three people familiar with the matter. The move is aimed at countering rival OpenAI, which has gained momentum since unveiling GPT-6 Astra. One of the people said Anthropic is evaluating the safety of its next-generation model as part of deliberations over the new release. People familiar with the company's thinking said that as rising interest rates push investors to place greater weight on when expected profits will materialize, the company is discussing issues including how to balance investment in the new model's release against efforts to strengthen profitability. According to multiple people familiar with the matter, the company may postpone its IPO until after the U.S. midterm elections in November. Anthropic declined to comment.
Artificial Intelligence
ロイター·23mRead more →
2

OpenAI CEO Altman to Address AI Safety at UN Security Council Meeting

OpenAI CEO Sam Altman will speak about AI safety measures at a Security Council meeting next week, as world leaders gather in New York for the UN General Assembly. A company spokesperson confirmed the plan on the 18th, noting that the Security Council will hold a meeting on AI and international security on the 23rd. According to the spokesperson, Altman will discuss the need for international coordination and common safety standards, as well as the measures the company is taking. According to diplomatic sources, an Anthropic executive is also expected to attend the meeting, though this has not yet been finalized. Several AI industry executives have warned in recent weeks that AI could soon evolve autonomously and escape human control, and have called for a coordinated slowdown in development.
Artificial Intelligence
ロイター·1hRead more →
▲

UBS Flags AI Science Shift as Investment Theme After OpenAI Proof

UBS Wealth Management says artificial intelligence is moving beyond text generation into scientific research, opening investment opportunities across AI infrastructure, pharmaceuticals, nuclear fusion, industrial materials and utilities. The shift was highlighted by OpenAI's recent mathematical proof related to the Navier-Stokes equations, a centuries-old fluid dynamics problem and one of seven Millennium Prize Problems, which OpenAI tackled using 10,000 autonomous AI agents working in parallel for 88 hours before formalizing the proof with Lean, a system for machine-checked mathematical validation. In pharmaceuticals, multi-agent AI systems can simulate millions of protein variations in the cloud, and more than 170 AI-designed programs are already in development or clinical evaluation, including Phase III trials. In nuclear fusion, reinforcement-learning systems can predict plasma disruptions around 200 milliseconds before they occur and adjust magnetic coils thousands of times per second, while AI models in materials science can test millions of elemental combinations daily in search of properties for lighter, higher-density batteries, lower-heat computing hardware and potential room-temperature superconductors. The broader investment case centers on AI becoming a tool for automating scientific research rather than simply generating content, with companies exposed to AI infrastructure, pharmaceuticals, industrial materials and utilities positioned to benefit as these technologies move toward commercial applications.
GOOGLLYMSFTNVDAUBSG.SW
Biotech & Genomic Medicine ▲Artificial Intelligence ▲Fusion Energy ▲
Investing.com·3hRead more →
© 2026 MarketDXNews